WO2025012213 - ARTIFICIAL SIGNAL PEPTIDES
National phase entry is expected:
Publication Number
WO/2025/012213
Publication Date
16.01.2025
International Application No.
PCT/EP2024/069205
International Filing Date
08.07.2024
Title **
[English]
ARTIFICIAL SIGNAL PEPTIDES
[French]
PEPTIDES SIGNAUX ARTIFICIELS
Applicants **
NOVOZYMES A/S
Inventors
PULTZ, Dennis
MOUILLON, Jean-Marie
HALLIN, Peter Fischer
BRAENDSTRUP, Eik
CHRISTENSEN, Pernille, Hvid
Priority Data
23184446.5
10.07.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1955 | |
| EPO | Filing, Examination, Granting | 8811 | |
| Japan | Filing, Examination, Granting | 2056 | |
| South Korea | Filing, Examination, Granting | 1779 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
21,741
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to nucleic acid constructs comprising a first polynucleotide encoding an artificial signal peptide and a second polynucleotide encoding a polypeptide having protease activity; expression vectors and host cells comprising said nucleic acid constructs; methods for producing polypeptides having protease activity; and fusion proteins comprising a protease polypeptide and an artificial signal peptide.[French]
La présente invention concerne des constructions d'acides nucléiques comprenant un premier polynucléotide codant pour un peptide signal artificiel et un second polynucléotide codant pour un polypeptide ayant une activité protéase ; des vecteurs d'expression et des cellules hôtes comprenant lesdites constructions d'acides nucléiques ; des procédés de production de polypeptides ayant une activité protéase ; et des protéines de fusion comprenant un polypeptide protéase et un peptide signal artificiel.